One Year Summary of Release Measurements for Lu177 Dotatate and Implications of the Proposed Revision to NRC Lu177 Release Criteria

被引：0
|
作者：
Cromer, M. M. [1 ]
Guta, A. [1 ]
Zoberi, J. E. [1 ]
Ramirez, J. L. Garcia [1 ]
Altman, M. B. [1 ]
Wall, P. D. H. [1 ]
Mikell, J. K. [1 ]
机构：
[1] Washington Univ, Sch Med St Louis, St Louis, MO 63110 USA
来源：
MEDICAL PHYSICS | 2024年 / 51卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：6583 / 6583
页数：1
相关论文
共 15 条
  • [1] Investigation into the excretion rates and contact restrictions of Lu177 Dotatate patients
    Hutton, L.
    Morgan, D.
    McGowan, D.
    Hallam, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S661 - S661
  • [2] Individualized dosimetry for Lu177 DOTATATE therapy - What difference does it make?
    Driscoll, Brandon
    Shessel, Andrea
    Laidley, David
    Breen, Stephen
    Yeung, Ivan
    Farcombe, Troy
    Zukotynski, Katherine
    Stodilka, Robert
    Brierley, James
    Myrehaug, Sten
    Juergens, Rosalyn
    Publicover, Julia
    Metser, Ur
    Mohan, Ravi
    Wong, Rebecca
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [3] Patient release after Lu-177 DOTATATE and Lu-177 PSMA 617 therapies
    Mair, C.
    Warwitz, B.
    Buxbaum, S.
    Virgolini, I. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S454 - S454
  • [4] Lu177 Dead Time Measurements on a Siemens Symbia T16 Gamma Camera
    Hooker, C. A.
    Dunlop, A.
    Kalogianni, E.
    Corcoran, B.
    Mulholland, N.
    Vivian, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S314 - S314
  • [5] Prevalence of clonal hematopoiesis in neuroendocrine tumor patients prior to lutetium 177 dotatate therapy (Lu177): A prospective trial of 36 patients
    Kusne, Yael
    Lasho, Terra
    Elsabbagh, Zaid
    Mangaonkar, Abhishek
    Eiring, Rachel
    Hobday, Timothy
    Starr, Jason
    Bekaii-Saab, Tanios
    Halfdanarson, Thorvardur
    Patnaik, Mrinal
    Sonbol, Mohamad
    CANCER RESEARCH, 2023, 83 (07)
  • [6] Prevalence of Clonal Hematopoiesis ( CH) in neuroendocrine tumor (NET) patients prior to Lutetium 177 dotatate therapy (Lu177) and the risk of cytopenia - A prospective study of 37 patients
    Sonbol, M.
    Kusne, Y.
    Lasho, T.
    Elsabbagh, Z.
    Mangaonkar, A.
    Ahn, D.
    Eiring, R.
    Hobday, T.
    Starr, J.
    Bekaii-Saab, T.
    Patnaik, M.
    Halfdanarson, T.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 150 - 150
  • [7] New Model For Lu-177 Dotatate Guide Decisions For Patient Restrictions And Release From Hospital
    Algarni, M.
    Stodilka, R.
    Riffel, J.
    Laidley, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S586 - S587
  • [8] Does Tumor Response Correlate With Quality of Life Changes Following LU177 DOTATATE Therapy for Neuroendocrine Tumors? Observations From a Multicenter Prospective Study (NCT02743741)
    Wong, R. K.
    Lajkosz, K.
    Myrehaug, S. D.
    Brierley, J.
    Laidley, D.
    Juergens, R.
    Liu, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E81 - E82
  • [9] Release criteria and exposure of caregivers and public after discharge of patients undergoing 131I-MIBG, 131I-NaI and 177Lu-DOTATATE therapies
    Polito, Claudia
    Ciucci, Davide
    Martire, Federica
    Donatiello, Salvatore
    Napolitano, Antonio
    Pizzoferro, Milena
    Villani, Maria Felicia
    Altini, Claudio
    Garganese, Maria Carmen
    Cannata, Vittorio
    EUROPEAN PHYSICAL JOURNAL PLUS, 2022, 137 (09):
  • [10] Release criteria and exposure of caregivers and public after discharge of patients undergoing 131I-MIBG, 131I-NaI and 177Lu-DOTATATE therapies
    Claudia Polito
    Davide Ciucci
    Federica Martire
    Salvatore Donatiello
    Antonio Napolitano
    Milena Pizzoferro
    Maria Felicia Villani
    Claudio Altini
    Maria Carmen Garganese
    Vittorio Cannatà
    The European Physical Journal Plus, 137
12